124 related articles for article (PubMed ID: 9672616)
1. The PI capsid region of Theiler's virus controls replication in mouse glial cell cultures.
O'Shea H; Crang J; Tonks P; Nash AA; Fazakerley JK
Arch Virol; 1997; 142(8):1521-35. PubMed ID: 9672616
[TBL] [Abstract][Full Text] [Related]
2. The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells.
Simas JP; Dyson H; Fazakerley JK
J Virol; 1995 Sep; 69(9):5599-606. PubMed ID: 7637006
[TBL] [Abstract][Full Text] [Related]
3. Infection of macrophage primary cultures by persistent and nonpersistent strains of Theiler's virus: role of capsid and noncapsid viral determinants.
Mena I; Roussarie JP; Brahic M
J Virol; 2004 Dec; 78(23):13356-61. PubMed ID: 15542687
[TBL] [Abstract][Full Text] [Related]
4. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus.
Aubert C; Brahic M
J Virol; 1995 May; 69(5):3197-200. PubMed ID: 7707550
[TBL] [Abstract][Full Text] [Related]
5. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.
Jarousse N; Syan S; Martinat C; Brahic M
J Virol; 1998 Sep; 72(9):7213-20. PubMed ID: 9696815
[TBL] [Abstract][Full Text] [Related]
6. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.
Steurbaut S; Rombaut B; Vrijsen R
J Neurovirol; 2007; 13(1):47-55. PubMed ID: 17454448
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid change determines persistence of a chimeric Theiler's virus.
Jarousse N; Grant RA; Hogle JM; Zhang L; Senkowski A; Roos RP; Michiels T; Brahic M; McAllister A
J Virol; 1994 May; 68(5):3364-8. PubMed ID: 7512164
[TBL] [Abstract][Full Text] [Related]
8. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
Senkowski A; Shim B; Roos RP
J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
[TBL] [Abstract][Full Text] [Related]
9. Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.
Massa PT; Ropka SL; Saha S; Fecenko KL; Beuler KL
J Virol; 2002 Aug; 76(16):8335-46. PubMed ID: 12134038
[TBL] [Abstract][Full Text] [Related]
10. An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system.
Jarousse N; Viktorova EG; Pilipenko EV; Agol VI; Brahic M
J Virol; 1999 Jan; 73(1):801-4. PubMed ID: 9847392
[TBL] [Abstract][Full Text] [Related]
11. Role of sialyloligosaccharide binding in Theiler's virus persistence.
Zhou L; Lin X; Green TJ; Lipton HL; Luo M
J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
[TBL] [Abstract][Full Text] [Related]
12. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system.
Lipton HL; Pritchard AE; Calenoff MA
J Gen Virol; 1998 May; 79 ( Pt 5)():1001-4. PubMed ID: 9603314
[TBL] [Abstract][Full Text] [Related]
14. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
Jnaoui K; Minet M; Michiels T
J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
[TBL] [Abstract][Full Text] [Related]
15. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.
Jnaoui K; Michiels T
J Virol; 1999 Sep; 73(9):7248-54. PubMed ID: 10438812
[TBL] [Abstract][Full Text] [Related]
17. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line.
Takata H; Obuchi M; Yamamoto J; Odagiri T; Roos RP; Iizuka H; Ohara Y
J Virol; 1998 Jun; 72(6):4950-5. PubMed ID: 9573263
[TBL] [Abstract][Full Text] [Related]
18. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
Adami C; Pritchard AE; Knauf T; Luo M; Lipton HL
J Virol; 1998 Feb; 72(2):1662-5. PubMed ID: 9445074
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Theiler's virus with altered tropism for the central nervous system.
Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
[TBL] [Abstract][Full Text] [Related]
20. Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line.
Obuchi M; Ohara Y; Takegami T; Murayama T; Takada H; Iizuka H
J Virol; 1997 Jan; 71(1):729-33. PubMed ID: 8985406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
